Thomas Reiser: How Can Medical and Healthcare Associations Stay Impactful in a Changing Environment?
Thomas Reiser, Former Executive Director at the International Society on Thrombosis and Haemostasis, reposted from ESAE on LinkedIn adding:
”What are the strategies that will keep medical-scientific and healthcare associations impactful and successful in an ever shifting environment full of challenges and opportunities?
I very much look forward to discussing what it will take to prepare for what lies ahead and stay relevant with my talented co-panelists at the upcoming ESAE – European Society of Association Executives Association Summit on March 26 in Brussels.
If you are leading a medical-professional or healthcare organization you don’t want to miss this session!”
Quoting European Society of Association Executives (ESAE)‘s post:
”Will Health Associations still be around in 20 years?
Demographics are shifting.
The shortage of health professionals is growing. Fewer young people are choosing medical careers.
What does this mean for membership-based medical societies? For congress participation?
For volunteer engagement? For long-term societal impact?
At EAS26, ESAE’s Health Community is bringing this urgent conversation to the stage in an interactive session that will explore how Health Associations can prepare for what lies ahead, from revenue diversification and congress strategy to sponsorship models and policy influence.
We are pleased to welcome as speakers:
- Davi Kaur, CEO, European Society for Emergency Medicine
- Frédéric Destrebecq, Executive Director, European Brain Foundation
- Alessandro Jacques Cortese, CEO, European Society for Radiotherapy and Oncology (ESTRO)
- Thomas Reiser, Industry Expert
If you work in the health Association space, this is not a conversation to miss at the European Association Summit!
You haven’t secured your EAS26 ticket yet?
Now it’s the time.”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 13:25Wolfgang Miesbach: Platelet Variation and How Do They Move Over Time?
-
Apr 15, 2026, 12:44Marwa Elnahas: 4Ts Scoring Tool for Heparin – Induced Thrombocytopenia
-
Apr 15, 2026, 12:27Laurent Bertoletti: Joining Global Experts to Improve Thrombosis Care in Cancer for the ICTHIC 16th Edition
-
Apr 15, 2026, 12:13Francesco Antonio Veneziano: JCDD MDPI Calls for Papers on Advances in Thrombosis and Antithrombotic Therapy
-
Apr 15, 2026, 11:05Julius Kyei Baffour: Understanding Thrombophilia Testing and Patient Risk
-
Apr 15, 2026, 09:10Shall I Bleed Less with Age? Just 2 Weeks Until the Webinar – EHC
-
Apr 15, 2026, 08:51Moustafa Abdou: Sutimlimab is Transforming Outcomes in Cold Agglutinin Disease
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care